Immediate Impact
37 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Recent Advances in Pyrimidine-Based Drugs
2024 Standout
Works of Amit Janu being referenced
Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).
2019
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Amit Janu | 350 | 247 | 85 | 101 | 86 | 552 | |
| Anne Ducassou | 248 | 180 | 102 | 106 | 67 | 533 | |
| Hüseyin Mertsoylu | 203 | 312 | 77 | 75 | 61 | 530 | |
| Meltem Ekenel | 273 | 287 | 113 | 97 | 51 | 578 | |
| Nuria Kotecki | 276 | 315 | 57 | 96 | 66 | 567 | |
| Rovel Colaco | 324 | 273 | 106 | 143 | 33 | 569 | |
| Yoshimasa Nakazato | 257 | 133 | 113 | 46 | 69 | 527 | |
| Katsuya Maebayashi | 249 | 142 | 103 | 121 | 38 | 564 | |
| Ramón Palmero | 317 | 371 | 60 | 47 | 48 | 618 | |
| Véronique Lorgis | 208 | 265 | 162 | 137 | 38 | 552 | |
| Vittorio Donato | 246 | 153 | 71 | 89 | 56 | 641 |
All Works
Login with ORCID to disown or claim papers
Loading papers...